Secundum atrial septal defects and methylenetetrahydrofolate reductase C677T polymorphism: A special category of ASDs?

Int J Cardiol. 2016 Nov 15:223:139-140. doi: 10.1016/j.ijcard.2016.08.212. Epub 2016 Aug 11.

Authors

Marco Zuin¹, Gianluca Rigatelli²

Affiliations

¹ Department of Cardiology, Rovigo General Hospital, Rovigo, Italy; Section of Internal and Cardiopulmonary Medicine, Department of Medical Science, University of Ferrara, Ferrara, Italy.
² Section of Cardiovascular Diagnosis and Endoluminal Interventions, Rovigo General Hospital, Italy. Electronic address: jackyheart71@yahoo.it.

PMID: 27537741
DOI: 10.1016/j.ijcard.2016.08.212

No abstract available

Keywords: Methylenetetrahydrofolate reductase C677T polymorphism; Secundum atrial septal defects.

MeSH terms

Cardiac Surgical Procedures* / adverse effects
Cardiac Surgical Procedures* / methods
Disease Management
Genetic Testing
Heart Septal Defects, Atrial* / blood
Heart Septal Defects, Atrial* / diagnosis
Heart Septal Defects, Atrial* / genetics
Heart Septal Defects, Atrial* / therapy
Humans
Methylenetetrahydrofolate Reductase (NADPH2) / genetics*
Mutation
Patient Selection
Polymorphism, Genetic
Postoperative Complications / etiology
Postoperative Complications / prevention & control*
Practice Guidelines as Topic
Risk Assessment / methods

Substances

MTHFR protein, human
Methylenetetrahydrofolate Reductase (NADPH2)